Document Detail


Reduction of plasma high-density lipoprotein cholesterol and increase of postheparin plasma hepatic lipase activity during progestin treatment.
MedLine Citation:
PMID:  6790199     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Twenty-seven menopausal women were given the synthetic progestin levonorgestrel for two weeks. The mean plasma high-density lipoprotein (HDL) cholesterol concentration decreased from 1.32 mmol/l to 1.01 mmol/l (p less than 0.001) during treatment. This was due to the selective reduction in plasma HDL2 cholesterol from 0.73 mmol/l to 0.44 mmol/l, whereas the plasma HDL3 cholesterol was not changed. The mean hepatic lipase (HL) activity of postheparin plasma increased from 20.6 to 35.3 mumol.h-1.ml-1 (p less than 0.001) while the lipoprotein lipase (LPL) activity was not changed. A significant inverse correlation existed between the HDL2 cholesterol concentration and HL activity both before (r=-0.49, p less than 0.01) and after (r=-0.39, p less than 0.05) treatment, and a significant correlation was observed between the changes in these two variables (r=0.39, p less than 0.05). These results are compatible with the hypothesis that HL participates in the regulation of plasma HDL2 levels and they suggest that progestin treatment reduces plasma HDL2 cholesterol concentration by increasing the hepatic lipase activity. It is not known whether this type of HDL2 reduction is accompanied by increased atherogenesis but as long as the issue is unresolved some caution is needed in the long-term use of levonorgestrel, particularly in women who simultaneously are given some other drug depressing plasma HDL2 concentration.
Authors:
M J Tikkanen; E A Nikkilä; T Kuusi; S Sipinen
Related Documents :
12860249 - Effects of various amounts of dietary plant sterol esters on plasma and hepatic sterol ...
8231659 - Higher levels of plasma cholesterol sulfate in patients with liver cirrhosis and hyperc...
18695239 - Therapeutic rnai targeting pcsk9 acutely lowers plasma cholesterol in rodents and ldl c...
8258959 - N-3 fatty acids reduce proteinuria in patients with chronic glomerular disease.
7357019 - Evidence for active phospholipase a in mouse plasma.
2719759 - Plasma vitamin e, apolipoprotein b and hdl-cholesterol in middle-aged men from southern...
1747999 - Luteotropic influence of the ovine uterus.
2146689 - Effects of standard cigarette and nicotine-less cigarette smoke inhalings on nicorandil...
16944669 - Csf versus serum leptin in narcolepsy: is there an effect of hypocretin deficiency?
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinica chimica acta; international journal of clinical chemistry     Volume:  115     ISSN:  0009-8981     ISO Abbreviation:  Clin. Chim. Acta     Publication Date:  1981  
Date Detail:
Created Date:  1981-10-25     Completed Date:  1981-10-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  1302422     Medline TA:  Clin Chim Acta     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  63-71     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cholesterol / blood*
Cholesterol, HDL
Female
Heparin
Humans
Levonorgestrel
Lipase / blood*
Lipoproteins, HDL / blood*
Liver / enzymology*
Menopause
Menstruation Disturbances / drug therapy*
Middle Aged
Norgestrel / therapeutic use*
Stereoisomerism
Chemical
Reg. No./Substance:
0/Cholesterol, HDL; 0/Lipoproteins, HDL; 57-88-5/Cholesterol; 6533-00-2/Norgestrel; 797-63-7/Levonorgestrel; 9005-49-6/Heparin; EC 3.1.1.3/Lipase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Low molecular mass IgM in urine of patients with primary and secondary renal diseases.
Next Document:  Alterations in circulating thyroid hormones and thyroxine binding globulin in chronic alcoholism.